ArticleFrontiers in pharmacology2022

Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C

Jiuzhou Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.